Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Healthcare Drug Manufacturers - Major Cannabis
Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Nova Mentis Life Science Corp. > Great NR
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by rcash1on Dec 20, 2017 2:05pm
108 Views
Post# 27198007

RE:RE:Great NR

RE:RE:Great NR
cr7epl wrote:

My Goldie is happy..............MONTREAL, Nov. 14, 2017 /CNW Telbec/ - LGC Capital Ltd.  (TSXV: LG) ("LGC") is pleased to announce its strategic partner Creso Pharma (CPH-ASX) disseminated the following news release yesterday about the launch of its cannabis-based product anibidiol® in Switzerland and Lichtenstein. Of note, Creso Pharma and LGC have agreed that LGC will be spearheading the distribution of this product in Southern Africa and Canada through LGC's investee businesses, subject to their obtaining all necessary regulatory approvals.

Creso Pharma and Virbac launch anibidiol® - the first Swiss approved hemp product with CBD as a complementary feed for companion animals


Who would have knows I'd hit 3400% on MYM hopefully we will see the same here one day ;)
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities